Comparison of Negative Pressure Wound Therapy with or without a Split-Thickness Skin Graft in the Surgical Management of Axillary Hidradenitis Suppurativa: A Retrospective Cohort Study.
Zak VinnicombeG V SinghJessica SpiersA L PounceyH McEvoyK LancasterPublished in: Plastic surgery (Oakville, Ont.) (2022)
Introduction: Negative pressure wound therapy (NPWT) alone or with the addition of a split-thickness skin graft (STSG) are 2 reconstructive options available after surgical excision of axillary hidradenitis suppurativa (HS). The aim of this study was to retrospectively examine patients undergoing these treatments and to assess clinical and patient-related outcome measures. Methods: A single-centre, retrospective analysis was conducted, evaluating surgical excision of axillary HS, with STSG and NPWT, or NPWT alone. Data collected included No. of post-operative clinic visits, time to heal, size of wound, disease recurrence, follow-up time, Dermatology Life Quality Index (DLQI), the Generalised Anxiety Disorder Assessment (GAD-7), the Patient Health Questionnaire Depression Scale (PHQ-9), Pain Visual Analogue Scale (PAINVAS2), the Brief Illness Perception Questionnaire (BIPQ), and Dermatology Visual Analogue Scale (DERMVAS). Two-tailed t -test and Mann-Whitney Wilcoxon U-tests were used to assess for significant relationships. Results: One hundred five patients were included in the study, 44 who received NPWT alone, and 61 who received NPWT + STSG. There was no significant difference in follow-up time ( P = .934) or No. of follow-up appointments between groups ( P = .287). There was a significant difference in time to heal between groups, with STSG + NPWT observing a mean time of 2.77 months and NPWT alone observing a mean time of 4.40 months ( P = .0006). There was no difference in patient-reported outcomes between the 2 groups. Conclusion: There is no difference in patient-reported outcomes with the addition of an STSG to NPWT after surgical excision of HS. Wide excision and use of NPWT alone is an effective procedure for the treatment of axillary HS.
Keyphrases
- patient reported outcomes
- hidradenitis suppurativa
- lymph node
- neoadjuvant chemotherapy
- sentinel lymph node
- patients undergoing
- wound healing
- ultrasound guided
- end stage renal disease
- primary care
- public health
- mental health
- chronic kidney disease
- chronic pain
- stem cells
- ejection fraction
- neuropathic pain
- cross sectional
- radiation therapy
- spinal cord injury
- squamous cell carcinoma
- patient reported
- risk assessment
- electronic health record
- sleep quality
- mesenchymal stem cells
- machine learning
- artificial intelligence
- drug induced
- free survival